ALLO
Allogene TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
ALLO vs peer average
64/100
ALLO vs. peer average (C vs. D)
Grade spread
B 1 · C 3 · D 2 · F 4
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
RCKT is the first available peer comparator.
A clinical-stage biotech comparison identified in stored earnings coverage. Different therapeutic programs and modalities make it useful mainly for assessing milestone and financing sensitivity, not for a direct price multiple.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ALLO
Allogene Therapeutics
RCKT
Rocket
Grade
C
F
Momentum
96
52
Value
41
41
Sentiment
54
33
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs RCKT
ALLO / RCKT
Grade Position
In line
ALLO vs. peer average (C vs. D)
64/100
Momentum
96
ALLOValue
41
ALLOSentiment
54
ALLORotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ALLO
RCKT is the first peer returned for this comparison set.